Estradiol Levels

How does our template work?

The Estradiol Levels Chart is a straightforward and efficient tool designed to assist healthcare professionals in tracking and interpreting estradiol levels in patients. Here's how to use it effectively:

Step 1: Download and prepare the chart

Click the Use Template button to open the template in the Carepatron app, which lets you customize templates to add branding or tailor it for your needs. Alternatively, press Download to download the printable PDF version of the Estradiol Levels Chart. You can fill it out digitally or print it for manual entry.

Step 2: Fill in patient details

Enter the patient's name and the date at the top of the chart. This ensures clear identification and record-keeping.

Step 3: Enter estradiol results

Record the patient's Estradiol (E2) levels in the designated space. It's important to note the measurement units (pg/mL or pmol/L) used in the blood test results.

Step 4: Add contextual information

If relevant, indicate the phase of the menstrual cycle during which the estradiol sample was taken. This context is crucial for accurate interpretation, as estradiol levels fluctuate throughout the menstrual cycle. Specifically, estradiol levels rise steadily during the follicular phase, peak before ovulation, and drop after ovulation.

Step 5: Interpretation and notes

Utilize the chart to compare the patient's E2 levels against standard estradiol ranges. Consider the patient's specific health context and add your professional interpretation and any pertinent notes in the provided space. Understanding normal estradiol levels is important for accurate interpretation and effective patient care.

When to use this chart?

The Estradiol Levels Chart is essential for healthcare professionals to understand estradiol hormone fluctuations. This chart is handy in various clinical scenarios and provides valuable insights for patient care.

• Monitoring menstrual health: For patients experiencing irregular menstrual cycles, this chart helps assess estradiol levels across different phases of the menstrual cycle.
• Fertility assessments: In cases of infertility or when assessing ovulation patterns, the chart can guide understanding estradiol's role in ovulation and reproductive health. It is also important for evaluating follicle stimulating hormone (FSH) levels, which are crucial in fertility assessments.
• Menopause management: This chart, along with a Menopause Hormone Levels Chart, helps evaluate symptoms related to menopause and perimenopause by tracking estradiol levels, which significantly fluctuate during these stages.
• Hormone Replacement Therapy (HRT): For patients undergoing hormone therapy, especially in transgender healthcare, the chart is crucial for monitoring hormone levels and adjusting treatment plans.
• Evaluating hormonal imbalances: The chart provides a framework for understanding estradiol variations in diagnosing conditions like polycystic ovary syndrome (PCOS) or estrogen dominance.

The Estradiol Levels Chart is a versatile and invaluable resource in a healthcare setting. It aids in making informed decisions, ensuring patient-specific care, and enhancing the understanding of hormonal health across various medical contexts.

Research & evidence

Ranges for estradiol levels at different phases of the menstrual cycle have been widely published, and techniques for measuring serum estradiol levels have been refined and improved since the first published values in the 1950s.

While the exact values can differ significantly between individuals, the relative estradiol changes throughout the menstrual cycle, such as the mid-cycle estradiol surge, have been consistently reported in journal articles from the 1970s (Korenman et al., 1974; Sherman & Korenman, 1975), 1980s (Hoff et al., 1984), 1990s (Fritz et al., 1992), 2000s (Burger et al., 2007) right up to present day endocrinology textbooks (Strauss & Barbieri, 2018; Taylor et al., 2020). The mid-cycle spike in estradiol is largely driven by the luteinizing hormone.

Therefore, the pattern of estradiol levels throughout the menstrual cycle is a well-researched topic with a wealth of evidence to support its various key features.

The values presented in this Estradiol Levels Chart resource are taken from Yen & Jaffe's Reproductive Endocrinology (Strauss & Barbieri, 2019) but are generally consistent with historically reported values. Within this textbook, Carmina et al. (2019) gives the range of Estradiol concentrations at the mid-cycle surge as 200-500 pg/mL, whereas Heitz et al. (1999) provide the peak values as 778 +/- 255.43 pg/mL, and another earlier study gives the peak values as about 320-520 pg/mL (Korenman et al., 1974).

As such, it is clear that a wide range of values at each stage of the menstrual cycle can be considered normal, and it should be remembered that the values cited in these sources indicate the sample population of each study. Individuals may have measurements higher or lower than these ranges without anything pathological necessarily causing these differences.

Therefore, this resource attempts to present a stylized diagram of estradiol fluctuations throughout the menstrual cycle, indicating the possible ranges of values at each phase shown.

References

Burger, H. G., Hale, G. E., Robertson, D. M., & Dennerstein, L. (2007). A review of hormonal changes during the menopausal transition: Focus on Melbourne women's midlife health project findings. Human Reproduction Update, 13(6), 559–565. https://doi.org/10.1093/humupd/dmm020

Carmina, E., Stanczyk, F., & Lobo, R. (2019). Evaluation of hormonal status. In Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management (8th ed.). Elsevier. https://doi.org/10.1016/B978-0-323-47912-7.00034-2

Heitz, N. A., Eisenman, P. A., Beck, C. L., & Walker, J. A. (1999). Hormonal changes throughout the menstrual cycle and increased anterior cruciate ligament laxity in females. Journal of Athletic Training, 34(22), 14–149. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1322903/

Korenman, S. G., Stevens, R. H., Carpenter, L. A., Robb, M., Niswender, G. D., & Sherman, B. M. (1974). Estradiol radioimmunoassay without chromatography: Procedure, validation and normal values. The Journal of Clinical Endocrinology & Metabolism, 38(4), 718–720. https://doi.org/10.1210/jcem-38-4-718

Sherman, B. M., & Korenman, S. G. (1975). Hormonal characteristics of the human menstrual cycle throughout reproductive life. Journal of Clinical Investigation, 55(4), 699–706. https://doi.org/10.1172/JCI107979

Strauss, J. F., & Barbieri, R. L. (Eds.). (2019). Yen & Jaffe's reproductive endocrinology: Physiology, pathophysiology, and clinical management (8th ed.). Elsevier. https://www.sciencedirect.com/book/9780323479127/yen-and-jaffes-reproductive-endocrinology

Taylor, H. S., Pal, L., & Seli, E. (2020). Speroff's clinical gynecologic endocrinology and infertility. Wolters Kluwer. https://www.wolterskluwer.com/en/solutions/ovid/speroffs-clinical-gynecologic-endocrinology-and-infertility-711